Alexis Meroney

Alexis Meroney

Associate Director, Business Development

Business Development
About

Alexis Meroney drives growth and innovation in the drug development and manufacturing sector, leveraging more than five years of business experience to identify and pursue new opportunities and build long-term relationships with clients and partners. 

Alexis has a proven track record of delivering well-qualified sales leads, managing complex projects, and communicating effectively with diverse stakeholders. She holds a degree from Stockton University.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Download Now

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More